Immunovant, Inc.
IMVT
$15.08
$0.191.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 598.91M | 713.97M | 374.69M | 472.94M | 560.01M |
| Total Receivables | 1.94M | 2.51M | 2.22M | 1.88M | 2.42M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 50.92M | 51.18M | 35.63M | 32.56M | 26.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 651.76M | 767.66M | 412.54M | 507.37M | 589.05M |
|
|
|||||
| Total Current Assets | 651.76M | 767.66M | 412.54M | 507.37M | 589.05M |
| Net Property, Plant & Equipment | 737.00K | 942.00K | 774.00K | 716.00K | 631.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.94M | 7.62M | 7.62M | 7.62M | -- |
| Total Assets | 661.44M | 776.22M | 420.93M | 515.71M | 589.68M |
|
|
|||||
| Total Accounts Payable | 7.84M | 17.66M | 19.82M | 20.73M | 11.04M |
| Total Accrued Expenses | 45.06M | 50.75M | 48.48M | 45.88M | 33.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 98.00K | 23.00K | 47.00K | 69.00K |
| Total Finance Division Other Current Liabilities | -- | 273.00K | -- | -- | -- |
| Total Other Current Liabilities | -- | 273.00K | -- | -- | -- |
| Total Current Liabilities | 52.90M | 68.78M | 68.32M | 66.65M | 45.02M |
|
|
|||||
| Total Current Liabilities | 52.90M | 68.78M | 68.32M | 66.65M | 45.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 52.90M | 68.78M | 68.32M | 66.65M | 45.02M |
|
|
|||||
| Common Stock & APIC | 1.97B | 1.95B | 1.48B | 1.47B | 1.46B |
| Retained Earnings | -1.36B | -1.24B | -1.13B | -1.02B | -912.83M |
| Treasury Stock & Other | 1.74M | 1.46M | 2.48M | 1.91M | 1.82M |
| Total Common Equity | 608.54M | 707.45M | 352.62M | 449.05M | 544.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 608.54M | 707.45M | 352.62M | 449.05M | 544.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 608.54M | 707.45M | 352.62M | 449.05M | 544.66M |
|
|
|||||